Dr. Samiullah Khan
My Social Links

Dr. Samiullah Khan

Associate Professor
The University of Lahore, Lahore, Punjab, Pakistan

Highest Degree
Ph.D. in Biochemistry from Islamia University Bahawalpur, Pakistan

Share this Profile

Area of Interest:

Biomedical Sciences
100%
Biochemistry
62%
Genetic Diversity
90%
Therapeutic Drug Monitoring
75%
Microbiology
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
40
Abstracts
2

Selected Publications

  1. Khan, M., A. Khan, M.Z.I. Butt, S. Khan, E. Asghar and M. Jamil, 2021. Alteration of serum liver enzymes level caused by cetirizine hydrochloride in exercise performers. J. Pharm. Res. Int., 33: 23-27.
    CrossRef  |  Direct Link  |  
  2. Khan, A., M.Z.I. Butt, Abdul Manan, E. Asghar, M. Jamil and S. Khan, 2021. Estimation of alanine transaminase (ALT), alkaline phosphate (ALP) and aspartate (AST) irrespective of dietary supplementation, body mass index and nature of exercise. J. Pharm. Res. Int., 33: 33-44.
    CrossRef  |  Direct Link  |  
  3. Jan, A.A., A. Khan, M.Z.I. Butt, S. Khan and E. Asghar et al., 2021. Alteration in metabolic cost of blood urea, serum albumin and oxidative stress induced by oral contraceptive pills (OCP) among elite females. J. Pharm. Res. Int., 33: 77-84.
    CrossRef  |  Direct Link  |  
  4. Rehman, K., G. Mustafa, M.A. Khan, Z. Rauf, N. Khan and S. Khan, 2019. Clinical biomarkers for diagnosis of damages in individuals with long-term exposure to X-rays. J. Coll. Physic. Surgeons Pak., 29: 616-620.
  5. Khan, A., S. Khan, S. Zia-ul-Islam, S. Khan and B.A. Khan, 2019. Oxidative stress and menstrual dysfunction caused by oral contraceptive pills. Latin Am. J. Pharm., 38: 2501-2504.
  6. Khan, A., S. Khan, S. Khan, S. Bhatti and S. Khan, 2019. Impact of low-intensity exercise on liver enzymes and antioxidants systems of the body. Int. J. Med. Res. Health Sci., 8: 148-155.
  7. Khan, A., S. Khan, S. Khan, D. Khan, S. Bharti and Z. Zahid, 2019. Exercise is more important than Medicines: A clinical Approach. Health Sci., 8: 75-79.
  8. Rehman, K., G. Mustafa, M.A. Khan, P.A. Shah, S. Khan S. Bakhsh and B.A. Khan, 2018. Oxidative stress and biochemical parameters as potential early biomarkers of chronic exposure to low dose X-radiations. Latin Am. J. Pharm., 37: 2137-2144.
    Direct Link  |  
  9. Niazi, Z.R., N. Khan, S. Khan, M. Alam and M.A. Kamal, 2018. Retraction notice: Potential application of venom proteins in designing of medicines for treating human neurodegenerative disorders. Protein Pept. Lett., 25: 633-642.
    CrossRef  |  
  10. Niaz, N., A. Bano, F. Fasim, R. Kausar, B.A. Khan, N. Zafar and B. Uzair, 2018. Synthesis, characterization and evaluation of antibacterial activity of copper oxide nanoparticles against clinical strains of Staphylococcus aureus. Pak. J. Pharm. Sci., 31: 1549-1553.
  11. Menaa, F., B.A. Khan and S. Khan, 2018. Advances in usage of venom proteins as diagnostics and therapeutic mediators. Protein Pept. Lett., 25: 610-611.
    CrossRef  |  
  12. Khan, S.U. and N. Khan, 2018. Enhanced production of biosurfactant by Pseudomonas aeruginosa isolate GW-7 under nitrogen and phosphate limiting conditions. Proceedings Pak. Acad. Sci.: B. Life Environ. Sci., 55: 47-56.
  13. Khan, S., M. Mudassir, N. Khan and A. Marwat, 2018. Brachdactyly instigated as a result of mutation in GDF5 and NOG genes in Pakistani population. Pak. J. Med. Sci., 34: 82-87.
    CrossRef  |  Direct Link  |  
  14. Khan, S., A. Gul, R. Noreen, S. Ahmed and M. Ashraf et al., 2018. Potential applications of venom peptides as anti-thrombotic agents for management of arterial and deep-vein thrombosis. Protein Pept. Lett., 25: 677-687.
    CrossRef  |  Direct Link  |  
  15. Khan, Naqab, Z.R. Niazi, A. Akhtar and M.M. Khan et al., 2018. Hyaluronidases: A therapeutic enzyme Protein Pept. Lett., 25: 663-676.
    CrossRef  |  
  16. Khan, N.Z., R. Niazi, K. Shah, S.A.H. Sherazi and S. Khan, 2018. Endothelial dysfunction: A cardiovascular risk. Gomal. J. Med. Sci., 16: 27-30.
  17. Khan, N., Z.R. Niazi, N.R. Khan, K. Shah and K. Rehman et al., 2018. Simulation studies and dynamic interaction of venom peptides with ion channels. Protein Pept. Lett., 25: 652-662.
    CrossRef  |  Direct Link  |  
  18. Hassan, M., A.T. Niazi, S. Khan and F. Gul, 2018. Antidiabetic and antihyperlipidemic effects of Artemisia absinthium L., Citrullus colocynthis (L.) Schrad and Gymnema sylvestre (Retz.) R. Br. ex Sm. on type II diabetes hyperlipidemic patients. Indian J. Traditional Know., 17: 233-239.
    Direct Link  |  
  19. Alam, M., N. Khan, K. Rehman, S. Khan and Z.R. Niazi et al., 2018. Evaluation of antibiotic resistant bacteria in underground drinking water and transfer of their resistant character to normal flora of the body. Pak. J. Pharm. Sci., 31: 657-662.
    Direct Link  |  
  20. Uzair, B., A. Hameed, S. Nazir, B.A. Khan, F. Fasim, S. Khan and F. Menaa, 2017. Synergism between Nigella sativa seeds extract and synthetic antibiotics against Mec A gene positive human strains of Staphylococcus aureus. Int. J. Pharmacol., 13: 958-968.
    CrossRef  |  Direct Link  |  
  21. Khan, L.U., R.A. Khan, S. Khan, S.A. Bano, F. Fasim and B. Uzair, 2017. Phytochemical screening and assessment of pharmacological properties of swertia chirayita (Roxb. ex Fleming) root methanolic extract. Int. J. Pharmacol, 13: 1000-1009.
    CrossRef  |  Direct Link  |  
  22. Khan, S.U. and S.S. Al-Saleh, 2015. Biochemical characterization of a factor X activator protein purified from Walterinnesia aegyptia venom. Blood Coagulation Fibrinolysis, 26: 772-777.
    CrossRef  |  Direct Link  |  
  23. Khan, S.U. and S.S. Al-Saleh, 2015. Biochemical characterization of a factor X activator protein purified from Walterinnesia aegyptia venom. Blood Coagulation Fibrinolysis, 26: 772-777.
    CrossRef  |  Direct Link  |  
  24. Al-Shammari, A.M., S.U. Khan, M.K. Al-Sadoon and S.S. Al-Saleh, 2013. Biochemical Characterization of Pyramid Viper, Echis pyramidum, Venom. Pak. J. Zool., 45: 1741-1749.
    Direct Link  |  
  25. Al-Saleh, S.S. and S.U. Khan, 2011. Purification and characterization of phosphodiesterase I from Walterinnesia aegyptia venom. Prep. Biochem. Biotech., 41: 262-277.
    CrossRef  |  Direct Link  |  
  26. Al-Saleh, S.S., M. Ashraf and S.U. Khan, 2009. Purification of phosphodiesterase I from Cerastes vipera venom, Biochemical and Biological properties of the purified enzyme. Proc. Pak. Acad. Sci., 46: 1-12.
  27. Al-Saleh, S.S., M. Ashraf and S.U. Khan, 2009. Biochemical characterization and some biological properties of the Phosphodiesterase I purified from Agistrodon bilineatus snake venom. Ind. J. Biochem. Biophy., 46: 221-229.
    Direct Link  |  
  28. Al-Saleh, S.S., M. Ashraf and S.U. Khan, 2009. Biochemical and Biological Properties of the Phosphodiesterase I purified from King Cobra Venom. J. Chem. Soc. Pak., 31: 292-303.
  29. Al-Saleh, S.S., H.K. Ghneim and S.U. Khan, 2003. The effect of crude and purified Cerastes vipera venom protein fractions on respiratory chain function in cultured human fibroblasts. Cell Physiol. Biochem., 15: 315-320.
    CrossRef  |  Direct Link  |  
  30. Al-Saleh, S.S., H.K. Ghneim, H.Y. Hadad and S.U. Khan, 2002. Separation and purification of Echis coloratus venom and some biological and biochemical effects of the proteins. Cell Biochem. Funct., 20: 153-162.
    CrossRef  |  Direct Link  |